INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS)

Abstract

Aim. To study influence of patient training in Health School on pharmacotherapy profile and cost in patients with ischemic heart disease (IHD).Material and methods. 100 out-patients with IHD (stable angina pectoris) were involved in the study and divided in two groups. Patients of preventive group were trained in Health School. Control group included untrained patients (typical practice). All patients were observed during 12 months.Results. ABC/VEN pharmacotherapy analysis showed inadequate hypolipidemic therapy and irrational antianginal therapy 12 months before study. Cost of treatment was unreasonably high because of active application of long-acting nitroglycerine and insufficient use of antianginal drugs corresponding to current evidence based recommendations (ex., beta-blockers). Improvement of pharmacotherapy profile and cost was observed in preventive group after Health School training due to increase of hypolipidemic drug and beta-blocker application and reduction of nitroglycerine consumption. There were not any changes of pharmacotherapy profile and cost in control group.Conclusion. Health School for patients is effective tool to improve IHD pharmacotherapy profile and cost. АВС/VEN analysis is relevant method for estimation of pharmacotherapy profile and cost in patients with IHD.

Keywords

• авс/ven analysis
• pharmacotherapy cost
• school for patients
• ischemic heart disease